J. Med. Microbiol. - Vol. 47 (1998), 401-405 0 1998 The Pathological Society of Great Britain and Ireland BACTERIAL ECOLOGY AND PATHOGENICITY: MODELS OF INFECTION
Trichomonas Vaginalis in Swabs - NHANES 2001-2002 Trichomonas Vaginalis Magee-Womens Hospital of UPMC Health System Pittsburgh PA Dr. Jeanne Jordan, Associate Prof. of Pathology 1
T. vaginalis has the ability to attach to host cells (cytoadherence) thereby establishing infection as the organism overcomes the constant secretion of the vagina.
APTIMA ® Trichomonas vaginalis Assay APTIMA Trichomonas vaginalis Assay 1 501923EN Rev. A For in vitro diagnostic use. For US export only. CONTENTS
Eastern Mediterranean Health Journal, Vol. 12, No. 5, 2006 679 Short communication Alternative drugs against Trichomonas vaginalis N.K. Mahdi, 1 Z.H. Gany 2 and M. Sharief 3 1 Department of Microbiology; 3 Department of Obstetrics and Gynaecology, College of Medicine; 2 Department of ...
http://vdi.sagepub.com/ Investigation Journal of Veterinary Diagnostic http://vdi.sagepub.com/content/2/3/167 The online version of this article can be found at:
J. Clin. Microbiol.€1981, 14(1):108. R. Bowie and William A. Black Carol E. Shaw, Michele E. Forsyth, William € Agar Media vaginalis ) from Human Blood
Method Target capture, Transcription-Mediated Amplification (TMA) and Hybridization Protection Assay (HPA). Target capture uses specific DNA capture oligonucleotides and magnetic beads for separation of target ribosomal Ribo Nucleic Acid (rRNA) from clinical specimens.
Clin. Microbiol. Rev.€1998, 11(2):300. Dino Petrin, Kiera Delgaty, Renuka Bhatt and Gary Garber € Trichomonas vaginalis Clinical and Microbiological Aspects of http://cmr.asm.org/content/11/2/300
Case report Malignant mesothelioma of the tunica vaginalis testis 1 C W MAK, MD, 2 T C CHENG, MD, 3 S S CHUANG, MD, 1 R H WU, MD, 1 C K CHOU, MD and